Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸帕洛诺司琼注射液 - NMPA Drug Approval Details

Approvals/NMPA/Palonosetron Hydrochloride Injection

Approved

化学药品

Palonosetron Hydrochloride Injection

北大医药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Oct 9, 2023
Approval ID: 7LeaeUlgF4k
Company: 北大医药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeUlgF4k
Approval Number: 国药准字H20130108
Generic Name: 盐酸帕洛诺司琼注射液
Generic Name En: Palonosetron Hydrochloride Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 5ml:0.25mg(以帕洛诺司琼计)
Reg Date: 2023-10-09
Company Name: 北大医药股份有限公司
Company Address: 重庆市北碚区水土镇方正大道21号
Production Company Name: 北大医药股份有限公司
Production Company Address: 重庆市北碚区水土镇方正大道21号附1号
Company Detail Path: /organization/pku-healthcare-corp-ltd
Production Company Detail Path: /organization/pku-healthcare-corp-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 9, 2023

Approval ID

7LeaeUlgF4k

Type

化学药品

Back to NMPA Approvals